Breaks Categories: Stock Spotlights

FridaySep 22, 2017 12:54 pm

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Simplifies Mobile Payments with O2O Commerce Marketplace

A recent Global Mobile Money Report by Nielsen (http://nnw.fm/fWG5j) shows that almost half of Chinese consumers will likely use a mobile device to make payments in restaurants, bars and retail stores—a much higher number than among consumers in the United States and Europe. Cashing in on China’s cashless trend and having recently upgraded its mobile payments capability, Moxian, Inc. (NASDAQ: MOXC) is doing business at the confluence of online retail and brick-and-mortar establishments, operating an online platform that utilizes social media to drive business to small and medium-sized enterprises (SMEs). An article further discussing this reads: “In early 2017, the…

Continue Reading

FridaySep 22, 2017 12:52 pm

NetworkNewsBreaks – Alternative Fuel Innovations Propel Greenkraft, Inc. (GKIT) to Success

Specializing in producing alternative fuel automotive products, including commercial trucks and engines, Greenkraft, Inc. (OTCQB: GKIT) is on a mission to offer clean, energy-efficient automotive products that boast a price advantage along with unmatched performance. The company is serving the commercial truck market with vehicles that are powered by alternative fuels that include CNG and LPG in classes 4, 5, 6 and 7. An article further discussing this reads: “Greenkraft’s new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for…

Continue Reading

FridaySep 15, 2017 12:33 pm

NetworkNewsBreaks – University of British Columbia to Conduct Clinical Study of Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Game-Changing Oral CBD Product

While cannabidiol and other marijuana-derived substances are traditionally smoked, this can cause damage to the lungs, and edible cannabis products have their drawbacks, too—typically being filled with sugars or other sweeteners to mask the unpleasant flavor associated with cannabis compounds. With its pioneering TurboCBD™ product, however, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds. An article further discussing this…

Continue Reading

FridaySep 15, 2017 12:28 pm

NetworkNewsBreaks – AppSwarm, Inc. (SWRM) Leverages Growth Strategy by Focusing on Key Revenue Streams

Building on $589,000 in revenue earned in 2016, AppSwarm, Inc. (OTC: SWRM) is going strong in 2017 with a vigorous growth strategy that is centered on a proprietary business model, known internally as the “Swarm.” This strategy involves measures like in-house development and assets gained through mergers and acquisitions. An article further discussing this topic reads: “The four key revenue streams driving the company’s progress include the incubation of apps, using completion of concept and development, market analysis, sales/marketing, and financial management services. AppSwarm is also highly engaged in social game development. It has developed highly relevant concepts internally, although…

Continue Reading

FridaySep 15, 2017 12:26 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, who is examining the treatment potential of cannabinoids in addressing disorders like addiction, schizophrenia, depression and post-traumatic stress disorder. Dr. Laviolette has been seeking ways to more effectively utilize chemicals found in marijuana to treat some of these illnesses, while Algae Dynamics has been taking a holistic approach by examining specific cannabinoids found in marijuana and combining that research with…

Continue Reading

FridaySep 15, 2017 12:22 pm

NetworkNewsBreaks – Recent Competitor Recalls Illustrate Importance of ABcann Global’s (TSX.V: ABCN) (OTCQB: ABCCF) Innovative, Pesticide-Free Cannabis Growth Practices

Recently, the Canadian government announced that Broken Coast Cannabis Ltd. was recalling several products sold in 2016 due to the discovery of two banned pesticides in random samples, and several other Canadian cannabis growers have also had product recalls this year after banned pesticides were discovered in their products during mandatory testing. Instances like these serve to further illustrate the importance of the controlled, pesticide-free medical marijuana growth practices of ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), which continues to meet product demand through its Napanee, Ontario, production facility and is also moving forward with expansion plans. An article further…

Continue Reading

FridaySep 01, 2017 11:13 am

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Profiting within Niche Cannabis Market

The legal cannabis market is exploding in North America and especially in Canada, where medical marijuana has been legal on a national level since 2001 and where sweeping legislation has been introduced in an effort to nationally legalize recreational use, as well. Among cannabis players preparing to capitalize should recreational legalization happen is Algae Dynamics Corp. (OTCQB: ADYNF). An excerpt from an article further discussing this reads: “Algae Dynamics is focused on cannabis oil extraction and medicine delivery systems, endeavoring to offer medical cannabis users a means of enjoying the benefits of medical marijuana without smoking. The company is preparing…

Continue Reading

FridaySep 01, 2017 11:11 am

NetworkNewsBreaks – Revolutionary trutankless Water Heaters from Bollente Companies, Inc. (BOLC) Gain Ground in Thriving Housing Construction Market

The housing construction market in the United States held strong in July 2017, with a seasonal adjusted rate of 1.22 million building permits, 1.15 million privately owned housing starts, and 1.17 million housing completions for private residences reported for the month. Construction trends are tending toward energy-efficient, water-saving multifamily residences in warm climates, which is fueling the demand for tankless water heaters such as those offered through the Bollente Companies, Inc. (OTC: BOLC) trutankless line. An excerpt from an article further discussing this reads: “The company’s industry partnerships for the trutankless line are an important growth driver and include the…

Continue Reading

FridaySep 01, 2017 11:09 am

NetworkNewsBreaks – InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Could Prove to Be a Cannabis Biotech Unicorn

The recent solar eclipse that enthralled the world has come and gone, but no shadow of an eclipse is on the horizon to blot out the progress of InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). As peer valuations have soared in Canada’s cannabis market, InMed continues its promising R&D efforts into the therapeutic benefits of marijuana, and this Vancouver, Canada-based company may just prove to be one of the unicorns of Canada’s cannabis biotech market. An excerpt from an article further discussing this reads: “InMed Pharmaceuticals has more to offer than the typical drug discovery and development company. Its triple…

Continue Reading

FridaySep 01, 2017 11:06 am

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) a Dark Horse in the Race to Treat Alzheimer’s

Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones. Wall Street is placing bets on who will win the race to treat Alzheimer’s, and India Globalization Capital (NYSE MKT: IGC) is one promising candidate with a compelling patent-pending treatment protocol. An excerpt from an article further discussing this reads: “IGC is a pioneer in the development of new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of…

Continue Reading